Gastrointestinal Impact and Tool Performance in Juvenile Systemic Sclerosis Using the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract, Version 2.0 Assessment
The UCLA GIT 2.0 captures the frequency and severity of GI symptoms in patients with jSSc and demonstrates acceptable validity and sensitivity to change. Although developed for adults, the instrument appears suitable for monitoring GI outcomes in pediatric patients with SSc in both research and clinical settings.
Authors
- Vibha Sood
- Amanda Robinson (ORCID: https://orcid.org/0000-0003-3296-2370)
- Kathryn S. Torok (ORCID: https://orcid.org/0000-0002-1662-143X)
- Haley Havrilla (ORCID: https://orcid.org/0000-0002-2100-230X)
- Sophie Stefancic
Institutions
- University of Pittsburgh (US)
- University of Utah (US)
- Children's Hospital of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/acr.25643
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47